The RING finger ubiquitin ligase RNF125/TRAC-1 down-modulates HIV-1 replication in primary human peripheral blood mononuclear cells.

CXCR4-using HIV-1 was previously shown to replicate more efficiently in a healthy donor-derived CD4(+) CD38(+) than in a CD4(+) CD38(-) T-cell subset after stimulation with interleukin (IL)-4. Here, we identified 3 cellular genes, which were expressed to a higher level in an IL-4-stimulated CD38(-) subset. One of the 3 genes, RNF125/TRAC-1, was involved in the down-regulation of HIV-1 replication not only in cell lines, but also in peripheral blood mononuclear cells. RNF125/TRAC-1 bears the RING finger domain, important for E3 ubiquitin protein ligase. Mutations in this domain of RNF125/TRAC-1 led to the loss of HIV-1 down-modulatory activity, suggesting that E3 ligase activity is necessary. In addition, the results of Northern blotting and reporter gene analysis indicated that RNF125/TRAC-1 function occurs at the viral transcription step. These results suggest that RNF125/TRAC-1 could function to recruit host factor(s) controlling HIV-1 transcription to the ubiquitin-proteasome pathway.

[1]  C. Wijmenga,et al.  The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes , 2003, Nature.

[2]  Y. Yarden,et al.  The RING Finger of c-Cbl Mediates Desensitization of the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[3]  F. Miedema,et al.  Changes in cytokine secretion patterns of CD4+ T-cell clones in human immunodeficiency virus infection. , 1994, Blood.

[4]  E. Maggi,et al.  Th1 versus Th2 responses in AIDS. , 1994, Current opinion in immunology.

[5]  D. Payan,et al.  A Novel E3 Ubiquitin Ligase TRAC-1 Positively Regulates T Cell Activation , 2005, The Journal of Immunology.

[6]  Y. Korin,et al.  Progression to the G1b Phase of the Cell Cycle Is Required for Completion of Human Immunodeficiency Virus Type 1 Reverse Transcription in T Cells , 1998, Journal of Virology.

[7]  M. Stevenson,et al.  HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.

[8]  K. Ikuta,et al.  RNA Interference Directed against Poly(ADP-Ribose) Polymerase 1 Efficiently Suppresses Human Immunodeficiency Virus Type 1 Replication in Human Cells , 2004, Journal of Virology.

[9]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[10]  N. Sonenberg,et al.  Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication , 1996, Journal of virology.

[11]  C. Sherr,et al.  The mononuclear phagocyte colony-stimulating factor (CSF-1, M-CSF). , 1989, Hematology/oncology clinics of North America.

[12]  R. Connor,et al.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.

[13]  U. Dianzani,et al.  Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? , 2000, AIDS.

[14]  N. Sonenberg,et al.  , M multiplication . type 1 gene expression and virus activation of human immunodeficiency virus block Tat-tumor necrosis factor synergistic Transdominant mutants of I kappa B alpha , 1996 .

[15]  C. M. Owens,et al.  The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.

[16]  M. L. Penn,et al.  CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Idziorek,et al.  T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)- mediated apoptosis of CD4+ T cells from human immunodeficiency virus- infected persons , 1995, The Journal of experimental medicine.

[18]  B. Wahrén,et al.  Increased levels of interferon‐gamma (IFN‐γ), IL‐4 and transforming growth factor‐beta (TGF‐β) mRNA expressing blood mononuclear cells in human HIV infection , 1994 .

[19]  F. Cosset,et al.  Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide. , 2002, Blood.

[20]  K. Shimotohno,et al.  p21Waf1/Cip1/Sdi1 Prevents Apoptosis as Well as Stimulates Growth in Cells Transformed or Immortalized by Human T-Cell Leukemia Virus Type 1-Encoded Tax , 2003, Journal of Virology.

[21]  E. Stanley,et al.  Colony-Stimulating Factor-1 Blockade by Antisense Oligonucleotides and Small Interfering RNAs Suppresses Growth of Human Mammary Tumor Xenografts in Mice , 2004, Cancer Research.

[22]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[23]  A. Haas,et al.  MdmX Is a RING Finger Ubiquitin Ligase Capable of Synergistically Enhancing Mdm2 Ubiquitination* , 2002, The Journal of Biological Chemistry.

[24]  Bertrand Friguet,et al.  Antiviral Activity of the Proteasome on Incoming Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[25]  K. Ikuta,et al.  Persistent Borna Disease Virus Infection Confers Instability of HSP70 mRNA in Glial Cells during Heat Stress , 2005, Journal of Virology.

[26]  J. Levy,et al.  Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation , 1995, Journal of virology.

[27]  K. Ikuta,et al.  Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules. , 2001, Virus research.

[28]  M. Clerici,et al.  Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children , 1998, The Lancet.

[29]  Alexander Varshavsky,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[30]  K. Jeang,et al.  A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter , 2003, Nature Cell Biology.

[31]  S. Nagata,et al.  pEF-BOS, a powerful mammalian expression vector. , 1990, Nucleic acids research.

[32]  R. Connor,et al.  Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.

[33]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[34]  A. Rice,et al.  Human Immunodeficiency Virus Type 1 Infection Induces Cyclin T1 Expression in Macrophages , 2004, Journal of Virology.

[35]  C. Pickart,et al.  Mechanisms underlying ubiquitination. , 2001, Annual review of biochemistry.

[36]  D. Venzon,et al.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. , 1993, The Journal of clinical investigation.

[37]  D. Littman,et al.  Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes , 1999, The Journal of experimental medicine.

[38]  K. Ikuta,et al.  Resting CD4(+) T cells with CD38(+)CD62L(+) produce interleukin-4 which contributes to enhanced replication of T-tropic human immunodeficiency virus type 1. , 2002, Virology.

[39]  V. Praloran.  Structure, biosynthesis and biological roles of monocyte-macrophage colony stimulating factor (CSF-1 or M-CSF). , 1991, Nouvelle revue francaise d'hematologie.

[40]  D. Kufe,et al.  Functional expression of the macrophage colony-stimulating factor receptor in human THP-1 monocytic leukemia cells. , 1992, Blood.

[41]  M. Clerici,et al.  The Th1-Th2 hypothesis of HIV infection: new insights. , 1994, Immunology today.

[42]  M. Yanai,et al.  Neuronal Calcium Sensor Protein Visinin-like Protein-3 Interacts with Microsomal Cytochrome b5 in a Ca2+-dependent Manner* , 2004, Journal of Biological Chemistry.

[43]  J Leibowitch,et al.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. , 1997, Science.

[44]  K. Ikuta,et al.  Human Immunodeficiency Virus Type 1 Subtype C Exhibits Higher Transactivation Activity of Tat than Subtypes B and E , 2002, Microbiology and immunology.

[45]  B. Cullen,et al.  Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  U. Schubert,et al.  The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K. Ikuta,et al.  Interleukin‐4 Up‐Regulates T‐Tropic Human Immunodeficiency Virus Type 1 Transcription in Primary CD4+ CD38+ T‐Lymphocyte Subset , 2005, Microbiology and immunology.

[48]  K. Aozasa,et al.  Epstein-Barr Virus (EBV)-Encoded RNA Promotes Growth of EBV-Infected T Cells through Interleukin-9 Induction , 2004, Cancer Research.

[49]  M. Malim,et al.  HIV‐1 infection of non‐dividing cells: evidence that the amino‐terminal basic region of the viral matrix protein is important for Gag processing but not for post‐entry nuclear import , 1997, The EMBO journal.

[50]  E. Helm,et al.  Demonstration of the Th1 to Th2 cytokine shift during the course of HIV‐1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry , 1997, AIDS.

[51]  L. Naldini,et al.  Interaction of Human Immunodeficiency Virus-Derived Vectors with Wild-Type Virus in Transduced Cells , 1999, Journal of Virology.

[52]  J. Zack.  The role of the cell cycle in HIV-1 infection. , 1995, Advances in experimental medicine and biology.

[53]  F. Malavasi,et al.  Human CD38: a glycoprotein in search of a function. , 1994, Immunology today.

[54]  R. Andino,et al.  Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses , 1994, Journal of virology.

[55]  F. Annunziato,et al.  Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection , 1994, The Journal of experimental medicine.

[56]  S. Pestka,et al.  Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. , 2006, Cancer research.